MIM
CDXS icon

MetLife Investment Management’s Codexis CDXS Stock Holding History

MetLife Investment Management’s Portfolio CDXS Stock Details CDXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,281
Closed -$86.1K – 2822
2025
Q3 		$86.1K Sell
35,281
-15,068
-30% -$41.1K ﹤0.01% 2713
2025
Q2 		$123K Buy
50,349
+30,533
+154% +$71.6K ﹤0.01% 2438
2025
Q1 		$53.3K Sell
19,816
-26,344
-57% -$102K ﹤0.01% 2687
2024
Q4 		$220K Buy
46,160
+28,569
+162% +$118K ﹤0.01% 2258
2024
Q3 		$54.2K Sell
17,591
-21,604
-55% -$66.8K ﹤0.01% 2747
2024
Q2 		$122K Buy
39,195
+4,270
+12% +$13.7K ﹤0.01% 2505
2024
Q1 		$122K Buy
34,925
+550
+2% +$1.73K ﹤0.01% 2447
2023
Q4 		$105K Hold
34,375
– – ﹤0.01% 2591
2023
Q3 		$65K Hold
34,375
– – ﹤0.01% 2788
2023
Q2 		$96.3K Buy
34,375
+10,708
+45% +$34.6K ﹤0.01% 2704
2023
Q1 		$98K Sell
23,667
-9,296
-28% -$48.8K ﹤0.01% 2562
2022
Q4 		$154K Hold
32,963
– – ﹤0.01% 2403
2022
Q3 		$200K Hold
32,963
– – ﹤0.01% 2307
2022
Q2 		$345K Hold
32,963
– – ﹤0.01% 1926
2022
Q1 		$680K Buy
32,963
+11,784
+56% +$244K ﹤0.01% 1588
2021
Q4 		$662K Hold
21,179
– – 0.01% 1341
2021
Q3 		$493K Sell
21,179
-3,434
-14% -$81.3K ﹤0.01% 1532
2021
Q2 		$558K Hold
24,613
– – ﹤0.01% 1503
2021
Q1 		$563K Hold
24,613
– – 0.01% 1455
2020
Q4 		$537K Hold
24,613
– – 0.01% 1456
2020
Q3 		$289K Hold
24,613
– – ﹤0.01% 1648
2020
Q2 		$281K Hold
24,613
– – ﹤0.01% 1694
2020
Q1 		$275K Hold
24,613
– – ﹤0.01% 1519
2019
Q4 		$394K Hold
24,613
– – ﹤0.01% 1594
2019
Q3 		$338K Hold
24,613
– – ﹤0.01% 1631
2019
Q2 		$454K Buy
24,613
+3,150
+15% +$60.7K ﹤0.01% 1538
2019
Q1 		$441K Hold
21,463
– – ﹤0.01% 1531
2018
Q4 		$358K Hold
21,463
– – ﹤0.01% 1564
2018
Q3 		$368K Hold
21,463
– – ﹤0.01% 1730
2018
Q2 		$309K Hold
21,463
– – ﹤0.01% 1702
2018
Q1 		$236K Hold
21,463
– – ﹤0.01% 1801
2017
Q4 		$179K Buy
+21,463
New +$149K ﹤0.01% 1989

Other funds holding CDXS

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's CDXS Position: Q4 2025 in Review

MetLife Investment Management sold out of Codexis (CDXS) in Q4 2025, closing a stake of 35,281 shares — an estimated $86.1K sold.

MetLife Investment Management first reported a position in CDXS in Q4 2017 and held it in 32 quarters. The position peaked at $680K in Q1 2022. 124 funds tracked by Wall St. Rank hold CDXS as of Q4 2025.

  • MetLife Investment Management reported no remaining Codexis position as of Q4 2025 after selling out during the quarter.
  • MetLife Investment Management sold 35,281 Codexis shares in Q4 2025, an estimated $86.1K.
  • MetLife Investment Management first reported a position in Codexis in Q4 2017 and held it in 32 quarters.
  • MetLife Investment Management's Codexis position peaked at $680K in Q1 2022.
  • 124 funds tracked by Wall St. Rank held Codexis as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.